Table 1.
Baseline demographic and clinical characteristics for the sub-analysis population (n = 125)a
| Baseline characteristics | Patients |
|---|---|
| Age, years | 59.4 ± 10.5 |
| Sex, male, n (%) | 89 (71.2) |
| Bodyweight, kg | 63.2 ± 12.8 |
| Dialysis duration, months | 84.3 ± 64.4 |
| Baseline ferritin (min, max), ng/mL | 70.5 ± 77.1 (5.0, 455.0) |
| TSAT, % | 23.0 ± 9.2 |
| Hemoglobin, g/dL | 10.5 ± 0.8 |
| MCH, pg | 31.6 ± 1.6 |
| MCV, fL | 96.6 ± 4.3 |
| Serum phosphorus, mg/dL | 5.4 ± 1.0 |
| Corrected calcium, mg/dL | 9.3 ± 0.7 |
| Intact PTH, pg/mL | 194.9 ± 119.4 |
| Albumin, g/dL | 3.9 ± 0.3 |
| nPCR, g/kg/day | 0.9 ± 0.1 |
| ESA dosage,b IU/week (n) | 4150 ± 2641 (115) |
a
Data are presented as mean ± SD, unless otherwise indicated.
b
Mean dosage in administered patients only (×200 equivalent was taken for darbepoetin and epoetin beta pegol). PTH, parathyroid hormone.